Work with us
Better treatments for children and young people affected by cancer are in our sight. No one part of the ecosystem can tackle this challenge alone. Those who join us are the ones ready to rewrite the playbook - people with innovative ideas for new therapeutics and approaches.
Whether you’re a researcher with a therapeutic opportunity, a potential partner or an impact investor, we want to hear from you.
Researchers
We partner with researchers to advance drug discovery and development efforts for childhood cancer treatments.
Going the extra mile
By collaborating with researchers and bringing together state-of-the-art facilities, expert resources, and a collaborative network of passionate professionals, we're aiming to overcome common obstacles in the way of development.
Support designed with you in mind
Our innovative approach provides your project with a unique combination of resourcing, expertise and investment that gives it the best chance of success.
Partners
By re-thinking conventional approaches to drug discovery and development, we are removing barriers and bringing promising new therapeutics to children and young people with cancer.
We’re looking for new partners from academia, industry, the non-profit sector and more.
Non-profits & charitable research funders
We need like-minded charities, research funders and foundations to get involved. Together we can increase the amount of funding available for drug discovery and development - improving the scale and diversity of research we progress in cancers affecting children and young people.
We're sparking change in our sector. This is an opportunity to join a movement and collaborate with like-minded individuals to advance treatments for childhood cancers more quickly and efficiently than ever before.
Wendy Jacquemet-Ross
Head of Partnerships, Childhood Cancer, LifeArc
News and events
We are creating a consortium united in the unwavering belief that we can challenge conventional approaches and accelerate translation of promising ideas into new therapies for children and young people affected by cancer.
Stay up to date on our latest news, events and research.
A little hero's journey: our duty to deliver
John Rainsbury on his son Will's cancer journey and the hope that new paediatric research might bring to children affected by cancer and their families.
C-Further unveils first therapeutic programmes dedicated to paediatric oncology
C‑Further launches its first targeted paediatric cancer programmes, collaborating with global academic and industry partners to advance new therapeutics for Ewing sarcoma, bone sarcoma, medulloblastoma and childhood AML.
From Chemo to CAR-T: A mum’s call for Child-First Drug Design
Courtney Addison on her son Cayden's cancer journey and the need for more targeted paediatric cancer treatments in an interview with C-Further.
Podcast: Changing the Playbook on Childhood Cancers
In this episode of RAREcast, Daniel Levine, a leading voice in oncology innovation, speaks with David Jenkinson of LifeArc about C-Further and what makes it a standout model in the current paediatric cancer translational science landscape.